Trial NCT04212650

View at ClinicalTrials.gov 
Org. Study IDs: 2019-15

Last trial update was posted on 2023-10-30

MeSH Interventions

Losartan

MeSH Conditions

Fibrosis Osteoarthritis, Hip

Other Conditions

Cartilage Damage Hip Impingement Syndrome Hip Osteoarthritis

Stopping Reasons

redesigned trial using another placebo controlled drug

Limitations And Caveats

Per opinion of the Principal Investigator, Losartan is now clinically indicated as a standard of care post-operative therapy for patients undergoing hip microfracture surgeries. The study was terminated early, resulting in a singular subject enrolled for data analysis. The subject elected to withdraw from the study prior to the first follow-up data collection timepoint.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID